Difference between revisions of "Part:BBa K1955003"
| Line 23: | Line 23: | ||
<br><br> | <br><br> | ||
<img src="https://static.igem.org/mediawiki/2016/2/2d/CGU_Taiwan--bio6.jpg" width=550px height=600px style="border:2px black solid;border-radius:8px;"></img><br><br> | <img src="https://static.igem.org/mediawiki/2016/2/2d/CGU_Taiwan--bio6.jpg" width=550px height=600px style="border:2px black solid;border-radius:8px;"></img><br><br> | ||
| − | <img src="https://static.igem.org/mediawiki/2016/4/42/J4.jpeg" width= | + | <img src="https://static.igem.org/mediawiki/2016/4/42/J4.jpeg" width=650px height=550px style="border:2px black solid;border-radius:8px;"></img><br><br> |
</div> | </div> | ||
Revision as of 05:32, 21 October 2016
pSB1C3-5'HYG
The promoter and the ribosomal binding site of Leishmania genome has not been elucidated yet. We selected the 5'- untranslated region of a highly expressed gene, P36, to be the promoter, RBS binding site and other extra function needed for Leishmania protein expression. We also added a Hygromycin resistant gene as drug selection marker. AS a dual functional biobrick of regulatory and selection marker, we provide the user the regulation of protein expression and also the drug selection system that is most commonly and effectively used in Leishmania experiments. This biobrick needs to use with the 3'UTR that we provide as the terminator of the Leishmania to perform a complete protein expression system for Leishamnia. Add the protein sequence in between the Leish-5'UTR-HYG and Leish-3'UTR for leishmania to expression your target protein.
(1) The basic part checked by PCR:
We used pSB1C3-5’HYG, pSB1C3-3’UTR, pSB1C3-HA, pSB1C3-OVA as template, to check the length of the inserts. The PCR reaction was performed with Taq polymerase, and screened in 0.8％ agarose gel by electrophoresis.
Sequence and Features